O'Sullivan J - Search Results

1

Opportunities for research in molecular radiotherapy.

Flux GD, O'Sullivan J, Gaze MN, Prise KM. Flux GD, et al. Br J Radiol. 2017 Mar;90(1071):20160921. doi: 10.1259/bjr.20160921. Epub 2017 Jan 5. Br J Radiol. 2017. PMID: 28055251 Free PMC article. Review.

2

A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.

Buffa FM, Flux GD, Guy MJ, O'Sullivan JM, McCready VR, Chittenden SJ, Dearnaley DP. Buffa FM, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1114-24. doi: 10.1007/s00259-003-1197-y. Epub 2003 May 22. Eur J Nucl Med Mol Imaging. 2003. PMID: 12761596 Clinical Trial.

3

Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used.

Divoli A, Bloch G, Chittenden S, Malaroda A, O'Sullivan JM, Dearnaley DP, Flux GD. Divoli A, et al. Cancer Biother Radiopharm. 2007 Feb;22(1):121-4. doi: 10.1089/cbr.2007.303. Cancer Biother Radiopharm. 2007. PMID: 17627420 Clinical Trial.

4

Radiation-induced bystander signalling in cancer therapy.

Prise KM, O'Sullivan JM. Prise KM, et al. Nat Rev Cancer. 2009 May;9(5):351-60. doi: 10.1038/nrc2603. Epub 2009 Apr 20. Nat Rev Cancer. 2009. PMID: 19377507 Free PMC article. Review.

5

A study of the biological effects of modulated 6 MV radiation fields.

Butterworth KT, McGarry CK, O'Sullivan JM, Hounsell AR, Prise KM. Butterworth KT, et al. Phys Med Biol. 2010 Mar 21;55(6):1607-18. doi: 10.1088/0031-9155/55/6/005. Epub 2010 Feb 17. Phys Med Biol. 2010. PMID: 20164535 Free PMC article.

6

18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?

Hanna GG, Carson KJ, Lynch T, McAleese J, Cosgrove VP, Eakin RL, Stewart DP, Zatari A, O'Sullivan JM, Hounsell AR. Hanna GG, et al. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1040-51. doi: 10.1016/j.ijrobp.2009.09.060. Epub 2010 Mar 28. Int J Radiat Oncol Biol Phys. 2010. PMID: 20350798

7

Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies.

Jain S, Coulter JA, Hounsell AR, Butterworth KT, McMahon SJ, Hyland WB, Muir MF, Dickson GR, Prise KM, Currell FJ, O'Sullivan JM, Hirst DG. Jain S, et al. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):531-9. doi: 10.1016/j.ijrobp.2010.08.044. Epub 2010 Nov 20. Int J Radiat Oncol Biol Phys. 2011. PMID: 21095075 Free PMC article.

8

Out-of-field cell survival following exposure to intensity-modulated radiation fields.

Butterworth KT, McGarry CK, Trainor C, O'Sullivan JM, Hounsell AR, Prise KM. Butterworth KT, et al. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1516-22. doi: 10.1016/j.ijrobp.2010.11.034. Epub 2011 Jan 27. Int J Radiat Oncol Biol Phys. 2011. PMID: 21277116 Free PMC article.

9

Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT).

McGarry CK, Butterworth KT, Trainor C, O'Sullivan JM, Prise KM, Hounsell AR. McGarry CK, et al. Phys Med Biol. 2011 Apr 21;56(8):2445-57. doi: 10.1088/0031-9155/56/8/008. Epub 2011 Mar 22. Phys Med Biol. 2011. PMID: 21427488

10

Assessing software upgrades, plan properties and patient geometry using intensity modulated radiation therapy (IMRT) complexity metrics.

McGarry CK, Chinneck CD, O'Toole MM, O'Sullivan JM, Prise KM, Hounsell AR. McGarry CK, et al. Med Phys. 2011 Apr;38(4):2027-34. doi: 10.1118/1.3562897. Med Phys. 2011. PMID: 21626935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,814 results

Search Page